Construction of protein fingerprint signature in serum and its significance for early diagnosis with chronic allograft nephropathy

National Medical Journal of China

Volumn 86, Issue 28, 2006, Pages 1966-1969

  Zhou, Shao Tang ^a   Yan, Ji Huan ^a   Yang, Cheng ^a   Zeng, Ning ^a   Wu, Ke ^a   Chen, Zhong Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Kidney disease; Kidney transplantation

Indexed keywords

BIOLOGICAL MARKER; PROTEIN;

ADULT; AGED; ARTICLE; CATION EXCHANGE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN REGULATION; EARLY DIAGNOSIS; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PREDICTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DATABASE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURVIVAL RATE; UPREGULATION;

ADULT; AGED; BLOOD PROTEINS; CHRONIC DISEASE; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE MAPPING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVORS;

EID: 33748037995     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Brian JN, Richard JB, Caroline LS, et al. The natural history of chronic allograft nephropathy. New Engl J Med, 2003,349: 2326-2333.
2. Brian JN, Jeremy RC. Chronic allograft nephropathy: current concepts and future directions. Transplantation, 2006, 81:643-654.
3. Sameer T, Howard G . Percutaneous needle biopsy of the transplant kidney: technique and complications. Am J Kidney Dis, 1989, 24: 13-17.
4. Jonathan E, Katz, Parag M, et al. Perspective on protein profiling of blood. Mini-reviews, 2005, 477-483.
5. Hanharan, Sundaram, McBride, et al. Evolution of endpoints for renal transplant outcome. Am J Transplant, 2003,3: 933-941.
6. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int, 1993, 44: 411.
7. Chinese source. 2005,85: 781-785.
8. Eieftherios P, Diamendios. Proteomic patterns in biological fluids: do they represent the future of cancer diagnosis? Clin Chem, 2003,49: 1272-1275.
9. Sarah A, Melissa MG, Helen RG. The use of proteomics for the assessment of clinical samples in research. Clin Biochem, 2004, 37: 943-952.
10. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359: 572-577.
11. Adam BL, Vlahou A, Semmes OJ, et al. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics, 2001,1: 1264-1270.
12. William C, Silverman BC. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg, 2003,237:660-665.
13. Stefan S, David R, John W. Proteomic-based detection of urine proteins with acute renal allograft rejection. J Am Soc Nephrol, 2004,15:219-227.
14. Emanuel P, Lance A, Liotta. The vision for a new diagnostic paradigm. Clin Chem, 2003,49:1276-1278.